Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ATAI - ATAI Life Sciences N.V.


IEX Last Trade
1.3
0   0%

Share volume: 394,716
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$1.30
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
30%
Profitability 25%
Dept financing 5%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
-0.76%
1 Month
-14.47%
3 Months
-22.62%
6 Months
-33.67%
1 Year
-15.58%
2 Year
-69.63%
Key data
Stock price
$1.30
P/E Ratio 
-3.76
DAY RANGE
N/A - N/A
EPS 
-$0.36
52 WEEK RANGE
$1.02 - $2.85
52 WEEK CHANGE
-$0.16
MARKET CAP 
218.139 M
YIELD 
N/A
SHARES OUTSTANDING 
167.799 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
1.43
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$479,115
AVERAGE 30 VOLUME 
$675,175
Company detail
CEO:
Region: US
Website:
Employees: 115
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

who we are: atai is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. our mission: we are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. our approach: by pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.

Recent news